Evonile Pharma Limited (BOM:500672)
India · Delayed Price · Currency is INR 1,900.65
-36.65 (-1.89%)
At close: Oct 16, 2026
Evonile Pharma Company Description
Evonile Pharma Limited is involved in the pharmaceutical business in India and internationally.
It operates Pharma International (Commercial operations), Development (Drug development), Biomedical Research, and Operations.
The company offers therapeutic products in the areas of bone and pain under the Voveran brand; transplantation immunology under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands.
It also offers neuroscience products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India.
As of July 29, 2026, Evonile Pharma Limited operates as a subsidiary of Waverise Investments Limited.
Evonile Pharma Limited
| Country | India |
| Founded | 1947 |
| Industry | Pharmaceutical Preparations |
| Employees | 57 |
| CEO | Vikas Gupta |
Contact Details
Address: Inspire BKC Mumbai, 400051 India | |
| Phone | 91 22 50243000 |
| Website | novartis.com |
Stock Details
| Ticker Symbol | 500672 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE234A01025 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Vikas Gupta | Chief Executive Officer |
| Bhagwat Deora | Chief Financial Officer |